# Safety and Pharmacokinetics of Nirsevimab in Immunocompromised Children

*PRI Rank #15 · Topics and Trends in Most Cited Pediatric health and respiratory diseases Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026/rank-15*

| Field | Value |
| --- | --- |
| Rank | #15 |
| 18m citations | 20 |
| Journal | PEDIATRICS |
| Year | 2024 |
| DOI | 10.1542/peds.2024-066508 |
| Corresponding authors | Joseph Domachowske, Ulrika Wählby Hamrén |
| Institution | State University of New York Upstate Medical University, United States |

**Ranking page:** [Topics and Trends in Most Cited Pediatric health and respiratory diseases Papers, Class of 2026](https://pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026)

**Paper link:** [10.1542/peds.2024-066508](https://doi.org/10.1542/peds.2024-066508)

## Topics

nirsevimab · Respiratory syncytial virus · RSV lower respiratory tract infection · immunocompromised children · extended half-life monoclonal antibody · MUSIC trial · pharmacokinetics · Primary immunodeficiency · transplantation · HIV infection · high-dose systemic corticosteroids · immunosuppressive chemotherapy · antidrug antibodies · nirsevimab clearance · protein loss · intramuscular injection · serum concentrations

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Pediatric health and respiratory diseases Papers, Class of 2026. https://pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026. Accessed 2026-07-14.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```